Literature DB >> 10995204

Translocation properties of novel cell penetrating transportan and penetratin analogues.

M Lindgren1, X Gallet, U Soomets, M Hällbrink, E Bråkenhielm, M Pooga, R Brasseur, U Langel.   

Abstract

Novel analogues of the cell-penetrating peptides penetratin and transportan were synthesized. The distribution of the biotin-labeled peptides in Bowes melanoma cell line has been investigated by indirect fluorescence with fluorescein-streptavidin detection. The time course of uptake of (125)I-labeled transportan analogues has been characterized in the same cell line. Molecular modeling was used to analyze the penetration and the orientation of molecules in a simulated biological membrane. The results, both from molecular modeling and fluorescence studies, imply that penetratin and transportan do not enter the cells by related mechanisms and that they do not belong to the same family of translocating peptides.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995204     DOI: 10.1021/bc990156s

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  23 in total

1.  Passage of cell-penetrating peptides across a human epithelial cell layer in vitro.

Authors:  Maria E Lindgren; Mattias M Hällbrink; Anna M Elmquist; Ulo Langel
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

2.  A molecular view on the interaction of the trojan peptide penetratin with the polar interface of lipid bilayers.

Authors:  Hans Binder; Göran Lindblom
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

3.  Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58).

Authors:  Rachel Tréhin; Ulrike Krauss; Roman Muff; Martina Meinecke; Annette G Beck-Sickinger; Hans P Merkle
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

4.  Characterization of the cell-penetrating properties of the Epstein-Barr virus ZEBRA trans-activator.

Authors:  Romy Rothe; Lavinia Liguori; Ana Villegas-Mendez; Bruno Marques; Didier Grunwald; Emmanuel Drouet; Jean-Luc Lenormand
Journal:  J Biol Chem       Date:  2010-04-09       Impact factor: 5.157

5.  Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs.

Authors:  P Sazani; S H Kang; M A Maier; C Wei; J Dillman; J Summerton; M Manoharan; R Kole
Journal:  Nucleic Acids Res       Date:  2001-10-01       Impact factor: 16.971

6.  Selection of peptide entry motifs by bacterial surface display.

Authors:  Sabine Taschner; Andreas Meinke; Alexander von Gabain; Aoife P Boyd
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

7.  Charge-dependent translocation of the Trojan peptide penetratin across lipid membranes.

Authors:  Hans Binder; Göran Lindblom
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

Review 8.  Biological applications of protein transduction technology.

Authors:  Panagiotis S Kabouridis
Journal:  Trends Biotechnol       Date:  2003-11       Impact factor: 19.536

9.  Peptide-mediated cellular uptake of cryptophane.

Authors:  Garry K Seward; Qian Wei; Ivan J Dmochowski
Journal:  Bioconjug Chem       Date:  2008-11-19       Impact factor: 4.774

Review 10.  Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

Authors:  S D Laufer; T Restle
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.